Omega-3/Heart Disease Amended Health Claim Without Disclaimer Proposed
This article was originally published in The Tan Sheet
Executive Summary
FDA should amend the approved health claim linking omega-3 fatty acids to a reduced risk of coronary heart disease by removing the disclaimer and extending the claim to foods, supplement industry members maintain in a June 23 petition
You may also be interested in...
Industry Qualifies Enthusiasm For Omega-3 Qualified Health Claim
FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend
Industry Qualifies Enthusiasm For Omega-3 Qualified Health Claim
FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend
Industry Qualifies Enthusiasm For Omega-3 Qualified Health Claim
FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: